Prot# CC-5013-MM-009: A Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Study of CC-5013 Plus Dexamethasone versus Dexamthasone Alone in Previously Treated Subjects with Multiple Myeloma